Lutein and Splenomegaly - a phase IV clinical study of FDA data

Summary:

Splenomegaly is reported as a side effect among people who take Lutein (lutein), especially for people who are male, 60+ old, also take Jakafi, and have Primary myelofibrosis.

The phase IV clinical study analyzes which people have Splenomegaly when taking Lutein. It is created by eHealthMe based on reports of 7,180 people who have side effects when taking Lutein from the FDA, and is updated regularly.

What is Lutein?

Lutein has active ingredients of lutein. It is often used in macular degeneration. eHealthMe is studying from 7,461 Lutein users. Check the latest studies of Lutein.

What is Splenomegaly?

Splenomegaly (enlargement of spleen) is found to be associated with 1,122 drugs and 1,477 conditions by eHealthMe. Check the latest studies of Splenomegaly.

On Jul, 10, 2026

7,180 people reported to have side effects when taking Lutein.
Among them, 19 people (0.26%) have Splenomegaly.

Among these 19 people:

What is the gender of people who have Splenomegaly when taking Lutein? *

female: 50 %
male: 50 %

What is the age of people who have Splenomegaly when taking Lutein? *

What are other drugs people take besides Lutein? *

What are other side effects people have besides Splenomegaly? *

Nasopharyngitis (inflammation of the nasopharynx): 9 people, 47.37%
Cough: 9 people, 47.37%
Fall: 8 people, 42.11%
Night Sweats (sweating in night): 8 people, 42.11%
Chest Injury: 7 people, 36.84%
Hyperhidrosis (abnormally increased sweating): 6 people, 31.58%
Hepatomegaly (abnormal enlargement of the liver): 6 people, 31.58%
Headache (pain in head): 6 people, 31.58%
Blood Count Abnormal: 6 people, 31.58%
Blood Thyroid Stimulating Hormone Increased: 6 people, 31.58%

What are the existing conditions these people have? *

Primary Myelofibrosis (primary disorder of the bone marrow): 9 people, 47.37%
Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 6 people, 31.58%
Anaemia (lack of blood): 5 people, 26.32%
Stress And Anxiety: 1 person, 5.26%
Multiple Myeloma (cancer of the plasma cells): 1 person, 5.26%
Insomnia (sleeplessness): 1 person, 5.26%
Gastric Disorder (disease of stomach): 1 person, 5.26%
Eye Disorder: 1 person, 5.26%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 1 person, 5.26%
Chronic Lymphocytic Leukaemia Recurrent (repeated cancer of blood cells known as lymphocytes): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Lutein and have Splenomegaly?

- Check whether Splenomegaly is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lutein:

Lutein (7,461 reports)

Splenomegaly treatments and more:

Splenomegaly (17,257 reports)

Browse all side effects of Lutein:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Splenomegaly:

Splenomegaly (1,123 drugs)

Browse all the conditions that are associated with Splenomegaly:

Splenomegaly (1,477 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lutein (the active ingredients of Lutein) and Lutein (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.